Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
234.40
5.2 (2.27%)
BSENSE

Apr 02

BSE+NSE Vol: 24.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "234.40",
    "chg": 5.2,
    "chgp": "2.27%",
    "dir": 1,
    "prev_price": "229.20",
    "mcapval": "2,371.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE416D01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "24.36 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 269,
    "sid": "730684",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2026",
      "details": "Please find enclosed herewith the Intimation regarding the Closure of Trading Window.",
      "source": "BSE"
    },
    {
      "caption": "Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10 2026",
      "datetime": "17-Feb-2026",
      "details": "Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10 2026.",
      "source": "BSE"
    },
    {
      "caption": "Rumour verification - Regulation 30(11)",
      "datetime": "13-Feb-2026",
      "details": "The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith Clarification Letter.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 24 Jul 25",
          "dt": "2025-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

31-Mar-2026 | Source : BSE

Please find enclosed herewith the Intimation regarding the Closure of Trading Window.

Communication To The Shareholders Regarding Tax Deduction On Interim Dividend Declared On February 10 2026

17-Feb-2026 | Source : BSE

Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10 2026.

Rumour verification - Regulation 30(11)

13-Feb-2026 | Source : BSE

The Company wishes to clarify the news item that appeared in CNBC Awaaz today i.e. February 13 2026. Please find attached herewith Clarification Letter.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bliss GVS Pharma Ltd has declared 50% dividend, ex-date: 24 Jul 25

stock-summary
SPLITS

Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08

stock-summary
BONUS

Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08

stock-summary
RIGHTS

No Rights history available